Rwanda
7 Vaccines Approved for Use in Rwanda
RNA
Moderna
Spikevax
Approved in 88 countries
70 trials in 24 countries
Approval Source: theeastafrican.co.ke
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: rbc.gov.rw
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: theeastafrican.co.ke
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Approval Source: rbc.gov.rw
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: rbc.gov.rw
4 in Clinical Trials in Rwanda
Protein Subunit
Novavax
Nuvaxovid
Approved in 40 countries
22 trials in 14 countries
DNA
Inovio
INO-4800
10 trials in 9 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries